A new study confirms that plasma p-tau181 levels can identify subjective cognitive decline (SCD) as a distinct early stage of ...

A new study from Columbia University Mailman School of Public Health and the Columbia Butler Aging Center suggests that risk ...

Discover insights into Anavex's ATTENTION-AD OLE trial results for early Alzheimer's, presented at AD/PD 2025. Click here to read my latest analysis.

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.

Researchers studying Alzheimer’s disease are using artificial intelligence ... But it took leveraging a knowledge graph, a database technology popularized by Google over a decade ago for its ...

Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery process by making it easier to sift through vast amounts of biomedical ...